361393-65-9

Usage

Uses

Used in Pharmaceutical Industry:
2,3-Dihydro-1-benzofuran-7-ylmethylamine is used as a potential pharmaceutical compound for its ability to interact with receptors in the central nervous system. Its unique chemical structure and properties make it a promising candidate for the development of new drugs with therapeutic applications.
Used in Medicinal Chemistry Research:
2,3-Dihydro-1-benzofuran-7-ylmethylamine is used as a subject of interest in medicinal chemistry research for its potential to contribute to the development of new drugs. Its chemical structure and potential biological activities may provide valuable insights and lead compounds for the discovery of novel therapeutic agents.
Used in Scientific Research and Exploration:
2,3-Dihydro-1-benzofuran-7-ylmethylamine is used as a subject of research and exploration in various scientific fields due to its unique chemical structure and potential range of biological activities. Further studies on 2,3-DIHYDRO-1-BENZOFURAN-7-YLMETHYLAMINE may reveal new insights and applications in areas such as drug discovery, chemical biology, and other related disciplines.

Upstream product

• 196799-45-8 2,3-dihydrobenzofuran-7-carbaldehyde 
• 1071448-66-2 C₁₀H₁₂O₄S 
• 1091606-28-8 C₈H₇LiO 
• 496-16-2 2.3-dihydrobenzofuran 
• 35700-40-4 2,3-dihydrobenzofuran-7-carboxylic acid 
• 870061-72-6 7-(bromomethyl)-2,3-dihydro-1-benzofuran 
• 151155-53-2 2,3-dihydro-1-benzofuran-7-ylmethanol 
• 134401-97-1 2,3-dihydrobenzofuran-7-carboxamide 
• 96042-30-7 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 
• 870061-73-7 7-(azidomethyl)-2,3-dihydro-1-benzofuran 

Relevant academic research and scientific papers

Synthesis and in vitro activity of N-benzyl-1-(2,3-dichlorophenyl)-1H- tetrazol-5-amine P2X7 antagonists

Synthesis and biological evaluation of a novel class of substituted N-benzyl-1-(2,3-dichlorophenyl)-1H-tetrazol-5-amine derivatives resulted in the identification of potent P2X7 antagonists. These compounds were assayed for activity at both the

ARYL FLUOROETHYL UREAS ACTING AS ALPHA 2 ADRENERGIC AGENTS

The invention provides well-defined aryl fluoroethyl ureas that are useful as selective alpha2 adrenergic agonists. As such, the compounds described herein are useful in treating a wide variety of disorders associated with modulation of alpha2 adrenergic receptors.

THERAPEUTIC FLUOROETHYLCYANO GUANIDINES

Disclosed herein is compound having a formula as described herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.

P2X7 receptor antagonists and methods of use

The invention is directed to compounds that are P2X7 antagonist and have the formula (I) or (II) or a pharmaceutically acceptable salt, prodrug, salt of a prodrug or a combination thereof, wherein R1, R2, and R3 /sub

AMINO-TETRAZOLES ANALOGUES AND METHODS OF USE

A compound having Formula (I) or Formula (II) is disclosed as an P2X7 antagonist, wherein A, B, C, Y, Y, Z, m, v, R1, R2, R3, R4, and R 5, are as defined in the description. Methods and compositions for treating disease or condition modulated by P2X7 are also disclosed.

Imidazole compounds

A novel class of imidazo heterocyclic compounds, pharmaceutical compositions comprising them and use thereof in the treatment and/or prevention of diseases and disorders related to the histamine H3 receptor. More particularly, the compounds are useful for the treatment and/or prevention of diseases and disorders in which an interaction with the histamine H3 receptor is beneficial.